BRPI0817158A2 - "método de identificar um paciente com câncer renal, kit, métodos e conjunto de compostos" - Google Patents

"método de identificar um paciente com câncer renal, kit, métodos e conjunto de compostos"

Info

Publication number
BRPI0817158A2
BRPI0817158A2 BRPI0817158A BRPI0817158A2 BR PI0817158 A2 BRPI0817158 A2 BR PI0817158A2 BR PI0817158 A BRPI0817158 A BR PI0817158A BR PI0817158 A2 BRPI0817158 A2 BR PI0817158A2
Authority
BR
Brazil
Prior art keywords
kit
identify
methods
cancer patient
kidney cancer
Prior art date
Application number
Other languages
English (en)
Inventor
Daniel S Chen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BRPI0817158A2 publication Critical patent/BRPI0817158A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
BRPI0817158 2007-11-09 2008-11-05 "método de identificar um paciente com câncer renal, kit, métodos e conjunto de compostos" BRPI0817158A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98688407P 2007-11-09 2007-11-09
PCT/US2008/082456 WO2009061800A2 (en) 2007-11-09 2008-11-05 Methods and compositions for diagnostic use in cancer patients

Publications (1)

Publication Number Publication Date
BRPI0817158A2 true BRPI0817158A2 (pt) 2015-04-14

Family

ID=40342593

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817158 BRPI0817158A2 (pt) 2007-11-09 2008-11-05 "método de identificar um paciente com câncer renal, kit, métodos e conjunto de compostos"

Country Status (13)

Country Link
US (2) US20090123930A1 (pt)
EP (1) EP2222874A2 (pt)
JP (1) JP2011502513A (pt)
KR (1) KR20100095571A (pt)
CN (1) CN101910416A (pt)
AU (1) AU2008324782A1 (pt)
BR (1) BRPI0817158A2 (pt)
CA (1) CA2703258A1 (pt)
IL (1) IL205246A0 (pt)
MX (1) MX2010005057A (pt)
RU (1) RU2010123381A (pt)
WO (1) WO2009061800A2 (pt)
ZA (1) ZA201002808B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010273585B2 (en) * 2009-07-13 2015-04-23 Genentech, Inc. Diagnostic methods and compositions for treatment of cancer
AU2010297344A1 (en) * 2009-09-17 2012-02-23 F. Hoffmann-La Roche Ag Methods and compositions for diagnostics use in cancer patients
CA2805618A1 (en) * 2010-07-19 2012-01-26 F. Hoffmann-La Roche Ag Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
KR20130126576A (ko) * 2010-07-19 2013-11-20 에프. 호프만-라 로슈 아게 항암요법에 반응할 가능성이 증가된 환자를 확인하는 방법
US10260097B2 (en) * 2011-06-02 2019-04-16 Almac Diagnostics Limited Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
WO2013106765A1 (en) 2012-01-13 2013-07-18 Genentech, Inc. Biological markers for identifying patients for treatment with vegf antagonists
JP2015522815A (ja) * 2012-06-26 2015-08-06 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 乳癌の治療用ベバシズマブ併用療法の血漿バイオマーカー
SG11201504023SA (en) * 2012-12-03 2015-06-29 Almac Diagnostics Ltd Molecular diagnostic test for cancer
US11015190B2 (en) 2013-09-17 2021-05-25 Lucence Life Sciences Pte Ltd Method of treating a patient having renal cancer
GB201409479D0 (en) * 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer
US11377693B2 (en) * 2014-12-09 2022-07-05 Merck Sharp & Dohme Llc System and methods for deriving gene signature biomarkers of response to PD-1 antagonists
KR101903522B1 (ko) * 2015-11-25 2018-11-23 한국전자통신연구원 다차원 건강데이터에 대한 유사사례 검색 방법 및 그 장치
WO2025098320A1 (en) * 2023-11-09 2025-05-15 Sun Jet Biotechnology Inc. Alpha-1 antitrypsin biomarkers for detecting and monitoring cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027216A1 (en) * 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
EP1869216B1 (en) * 2005-04-13 2012-08-15 Oncotest GmbH Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds
JP2009532029A (ja) * 2006-03-31 2009-09-10 バイエル・ヘルスケア・エルエルシー 癌の予報および予後方法および癌治療のモニタリング

Also Published As

Publication number Publication date
IL205246A0 (en) 2010-12-30
US20090123930A1 (en) 2009-05-14
US20110151468A1 (en) 2011-06-23
ZA201002808B (en) 2011-07-27
JP2011502513A (ja) 2011-01-27
KR20100095571A (ko) 2010-08-31
EP2222874A2 (en) 2010-09-01
MX2010005057A (es) 2010-05-19
WO2009061800A3 (en) 2009-07-16
RU2010123381A (ru) 2011-12-20
CN101910416A (zh) 2010-12-08
AU2008324782A1 (en) 2009-05-14
CA2703258A1 (en) 2009-05-14
WO2009061800A2 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
BRPI0817158A2 (pt) "método de identificar um paciente com câncer renal, kit, métodos e conjunto de compostos"
DK1997793T3 (da) Heteromolekylære metal-humussyre-komplekser (chelater)
DE602005024846D1 (de) Blutdialysator
IL197217B (en) Novel anti-cd38 antibodies for the treatment of cancer
ZA201000150B (en) Artificial kidney
IL225386A (en) Method for diagnosis of cancer by detecting an ereg protein
BRPI0719626A2 (pt) '' composto ''
EP1971389A4 (en) REMOVABLE BLOOD LINE FILTER
BRPI0718313A2 (pt) Conjunto de cateter
EP2332943A4 (en) NOVEL CONDENSATE AMINODIHYDROTHIAZINE DERIVATIVE
ATE499453T1 (de) Zugerichtetes leder
EP1855738A4 (en) CATHETER CONNECTOR
BRPI0914533A2 (pt) "métodos"
EP2171592A4 (en) PARALLELIZATION OF SEQUENCIAL FRAMEWORK CONDITIONS USING TRANSACTIONS
PT2170956E (pt) Tratamento de tumores utilizando um anticorpo anti-l1 específico
DE602007008063D1 (de) Hydraulikspanner
DE602005014851D1 (de) Seilorganisator
FR2908513B1 (fr) Systeme d'echantillonnage en temps equivalent
EP1732579A4 (en) HERB EXTRACT FOR RENAL DISORDERS
BRPI0815252A2 (pt) "aparato marcador"
DE502005003619D1 (de) Mehrlumige Aortenkanüle
FI20040134A0 (fi) Laskutusjärjestely
ITMO20060009U1 (it) Organizer attivita' professionali
FI6799U1 (fi) Säilytyskansio
FIU20040301U0 (fi) Säilytyskansio

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.